CTLA4 and neoplasm: A particularly enlightening scenario that unveils the intricate connection between autoimmunity and anti-tumor responses is observed with the use of immune checkpoint inhibitors (ICI) targeting PD-1 and CTLA-4 inhibitory molecules (Figure 2).